| Gene symbol | TP53 | Synonyms | BCC7, BMFS5, LFS1, P53, TRP53 | Type of gene | protein-coding |
| Chromosome | 17 | Map location | 17p13.1 | dbXrefs | |
| Gene perturbation-related omics dataset | PerturbAtlas | PertOrg | ||||
| Description | tumor protein p53 | ||||
| GTO ID | GTC1161 |
| Trial ID | NCT00004041 |
| Disease | Malignant Glioma |
| Altered gene | P53 |
| Therapeutic/Target gene | Therapeutic gene |
| Therapy | Gene transfer |
| Treatment | AdV5.CMV-p53 |
| Phase | Phase1 |
| Recruitment status | Completed |
| Title | Phase I Trial of Adenovirus-Mediated Wild-Type P53 Gene Therapy for Malignant Gliomas |
| Year | 1999 |
| Country | United States |
| Company sponsor | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins |
| Other ID(s) | NABTC-9703|CDR0000066871 |
| Vector information | |||||||||||||
|
|||||||||||||
| Cohort 1 | |||||||
|
|||||||